Somatostatin receptor subtype 2A (SSTR2A) and human epidermal growth factor receptor 2 (HER2) expression in GC tissues of 51 patients were analyzed by Romiti et al. They observed SSTR2A expression in 74.5% of patients with a predominance in well and moderately differentiated GC. This evidence concerns the gene ERBB2 and gastric cancer.